Literature DB >> 18444812

Clinical presentation of nipah virus infection in Bangladesh.

M Jahangir Hossain1, Emily S Gurley, Joel M Montgomery, Michael Bell, Darin S Carroll, Vincent P Hsu, P Formenty, A Croisier, E Bertherat, M A Faiz, Abul Kalam Azad, Rafiqul Islam, M Abdur Rahim Molla, Thomas G Ksiazek, Paul A Rota, James A Comer, Pierre E Rollin, Stephen P Luby, Robert F Breiman.   

Abstract

BACKGROUND: In Bangladesh, 4 outbreaks of Nipah virus infection were identified during the period 2001-2004.
METHODS: We characterized the clinical features of Nipah virus-infected individuals affected by these outbreaks. We classified patients as having confirmed cases of Nipah virus infection if they had antibodies reactive with Nipah virus antigen. Patients were considered to have probable cases of Nipah virus infection if they had symptoms consistent with Nipah virus infection during the same time and in the same community as patients with confirmed cases.
RESULTS: We identified 92 patients with Nipah virus infection, 67 (73%) of whom died. Although all age groups were affected, 2 outbreaks principally affected young persons (median age, 12 years); 62% of the affected persons were male. Fever, altered mental status, headache, cough, respiratory difficulty, vomiting, and convulsions were the most common signs and symptoms; clinical and radiographic features of acute respiratory distress syndrome of Nipah illness were identified during the fourth outbreak. Among those who died, death occurred a median of 6 days (range, 2-36 days) after the onset of illness. Patients who died were more likely than survivors to have a temperature >37.8 degrees C, altered mental status, difficulty breathing, and abnormal plantar reflexes. Among patients with Nipah virus infection who had well-defined exposure to another patient infected with Nipah virus, the median incubation period was 9 days (range, 6-11 days).
CONCLUSIONS: Nipah virus infection produced rapidly progressive severe illness affecting the central nervous and respiratory systems. Clinical characteristics of Nipah virus infection in Bangladesh, including a severe respiratory component, appear distinct from clinical characteristics reported during earlier outbreaks in other countries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444812     DOI: 10.1086/529147

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  88 in total

Review 1.  The immune response to Nipah virus infection.

Authors:  Joseph Prescott; Emmie de Wit; Heinz Feldmann; Vincent J Munster
Journal:  Arch Virol       Date:  2012-06-06       Impact factor: 2.574

Review 2.  Emerging viral infections of the central nervous system: part 2.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-09

Review 3.  Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Authors:  Michelle D Audsley; Gregory W Moseley
Journal:  World J Virol       Date:  2013-05-12

4.  Piloting the promotion of bamboo skirt barriers to prevent Nipah virus transmission through date palm sap in Bangladesh.

Authors:  Nazmun Nahar; Utpal Kumar Mondal; M Jahangir Hossain; M Salah Uddin Khan; Rebeca Sultana; Emily S Gurley; Stephen P Luby
Journal:  Glob Health Promot       Date:  2014-04-22

5.  Using network theory to identify the causes of disease outbreaks of unknown origin.

Authors:  Tiffany L Bogich; Sebastian Funk; Trent R Malcolm; Nok Chhun; Jonathan H Epstein; Aleksei A Chmura; A Marm Kilpatrick; John S Brownstein; O Clyde Hutchison; Catherine Doyle-Capitman; Robert Deaville; Stephen S Morse; Andrew A Cunningham; Peter Daszak
Journal:  J R Soc Interface       Date:  2013-02-06       Impact factor: 4.118

6.  Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism.

Authors:  Michael J Ciancanelli; Valentina A Volchkova; Megan L Shaw; Viktor E Volchkov; Christopher F Basler
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

7.  Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA.

Authors:  Cheng-Feng Chiang; Michael K Lo; Paul A Rota; Christina F Spiropoulou; Pierre E Rollin
Journal:  Virol J       Date:  2010-06-03       Impact factor: 4.099

8.  A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Authors:  Katharine N Bossart; Zhongyu Zhu; Deborah Middleton; Jessica Klippel; Gary Crameri; John Bingham; Jennifer A McEachern; Diane Green; Timothy J Hancock; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Lin-Fa Wang; Christopher C Broder
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

9.  Cluster of Nipah virus infection, Kushtia District, Bangladesh, 2007.

Authors:  Nusrat Homaira; Mahmudur Rahman; M Jahangir Hossain; Nazmun Nahar; Rasheda Khan; Mostafizur Rahman; Goutam Podder; Kamrun Nahar; Dawlat Khan; Emily S Gurley; Pierre E Rollin; James A Comer; Thomas G Ksiazek; Stephen P Luby
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

10.  Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007.

Authors:  Stephen P Luby; M Jahangir Hossain; Emily S Gurley; Be Nazir Ahmed; Shakila Banu; Salah Uddin Khan; Nusrat Homaira; Paul A Rota; Pierre E Rollin; James A Comer; Eben Kenah; Thomas G Ksiazek; Mahmudur Rahman
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.